Analysts' Actions: CSCO GOOG TEVA RVBD PCS

NEW YORK (TheStreet) -- CHANGE IN RATINGS:

Advance Auto Parts ( AAP) upgraded at JP Morgan to overweight, JP Morgan said. Company can gain market share in an industry that's likely to see a soft landing in 2013.

Aecom ( ACM) upgraded at BofA/Merrill from underperform to buy, Bank of America/Merrill Lynch said. $35 price target. Company is seeing a solid recovery in free cash flow.

Activision Blizzard ( ATVI) upgraded at Sterne Agee from neutral to buy, Sterne Agee said. $17 price target. Company is positioned well for the next business cycle and the company will likely buy back a significant amount of shares.

Biogen Idec ( BIIB) upgraded at Citigroup to buy from neutral, Citigroup said. $187 price target. Expecting a solid Tecfidera launch.

Celgene ( CELG) rated new outperform at JMP. $130 price target. Company is a market leader and can continue to deliver solid growth.

Discover ( DFS) upgraded at Credit Suisse from neutral to outperform, Credit Suisse said. $47 price target. Company can deliver the best growth in the industry at the lowest valuation.

DSW ( DSW) rated new buy at Sterne Agee. $75 price target. Company is a market leader and can deliver above-average growth for the foreseeable future.

Guess ( GES) upgraded at Wedbush from neutral to outperform, Wedbush said. $34 price target. There are early signs that the business is turning around in North America.

Gartner ( IT) downgraded at Piper from overweight to neutral, Piper Jaffray said. Valuation call, based on a $52 price target.

Annaly Capital ( NLY) upgraded at Sterne Agee from underperform to neutral, Sterne Agee said. Valuation call, based on a $14.25 price target.

Nuance ( NUAN) downgraded at Needham from buy to hold, Needham said. Company is seeing lower international sales and demand from healthcare customers.

MetroPCS ( PCS) upgraded at Nomura from reduce to neutral, Nomura said. $9.50 price target. Worst news appears to be behind the company.

Riverbed ( RVBD) downgraded at FBR from outperform to market perform, FBR Capital Markets said. $20 price target. Company is seeing lower core sales.

Riverbed downgraded at Cantor from buy to hold, Cantor Fitzgerald said. $20 price target. Core products are showing little growth.

Teva ( TEVA) downgraded at Canaccord to hold, Canaccord Genuity said. $45 price target. Company turnaround is taking longer than expected.

Trinity Industries ( TRN) downgraded at UBS to neutral from buy, UBS said. $41 price target. Continued growth in tank car orders increasingly challenging.

Westlake Chemical ( WLK) upgraded at UBS to neutral from sell, UBS said. $90 price target. Softer ethane pricing outlook.

STOCK COMMENTS / EPS CHANGES

Biogen Idec ( BIIB) numbers increased at Credit Suisse. BIIB estimates were raised through 2016, Credit Suisse said. Tysabri deal should add to earnings. Outperform rating and new $185 price target.

Cigna ( CI) numbers raised at Jefferies. Shares of CI now seen reaching $71, Jefferies said. Estimates also raised on its upward 2013 revision. Buy rating.

Cisco ( CSCO) target raised at Citigroup to $24, Citigroup said. Continued execution in an improving macro environment. Buy rating.

Coinstar ( CSTR) estimates, target cut at JP Morgan.CSTR estimates were reduced through 2014, JP Morgan said. Company is seeing lower sales. Neutral rating and new $51 price target.

Eastman Chemical ( EMN) target raised at Jefferies. Shares of EMN now seen reaching $79, Jefferies said. Favorable pricing in 2013. Hold rating.

Google ( GOOG) added to Best Ideas List at Morgan Stanley. Company can deliver 15% compound annual free cash flow growth over the next five years. $932 price target.

CarMax ( KMX) numbers raised at Oppenheimer. Shares of KMX now seen reaching $46, Oppenheimer said. Estimates also raised on attractive market share growth. Outperform rating.

LinkedIn ( LNKD) estimates, target raised at BMO. Shares of LNKD now seen reaching $130, according to BMO Capital. Estimates also increased, as new products are driving growth. Market Perform rating.

Microchip Technology ( MCHP) numbers raised at Jefferies. Shares of MCHP now seen reaching $41, Jefferies said. Estimates also raised on fourth quarter beat. Buy rating.

Microchip estimates, target raised at Credit Suisse. Shares of MCHP now seen reaching $40, according to Credit Suisse. Estimates also increased, as the company is seeing higher core demand and benefits from acquisitions. Outperform rating.

Martin Marietta ( MLM) numbers raised at Jefferies. Shares of MLM now seen reaching $114, Jefferies said. Estimates also raised stronger demand enabling fourth quarter beat. Buy rating.

NCR ( NCR) estimates, target boosted at JP Morgan. Shares of NCR now seen reaching $37, according to JP Morgan. Estimates also upped, given the company's new guidance. Overweight rating.

OpenTable ( OPEN) numbers lowered at Oppenheimer. Shares of OPEN now seen reaching $49, Oppenheimer said. Estimates also lowered on slowing earnings growth. Perform rating.

Patterson-UTI ( PTEN) numbers upped at BMO. PTEN estimates were boosted through 2014, BMO Capital said. Company is seeing higher demand for pressure pumping. Outperform rating and new $25 price target.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain